Lamictal pay-for-delay case sent back to New Jersey federal court
A US appeals court has sent back a case over an alleged pay-for-delay agreement between GlaxoSmithKline and Teva on epilepsy drug Lamictal for the lower court to reconsider its dismissal of...To view the full article, register now.
Already a subscriber? Click here to view full article